Scientists have developed a tool that promises to reshape the way we study disease and disease treatment on a cellular level. Scientists have developed scGen, an AI-powered tool for predicting a cell's behavior in silico. scGen will help map and study cellular response to disease and treatment beyond experimentally available data.